
Merck to onshore cancer drug Keytruda in Wilmington
WILMINGTON — Merck & Company revealed that its $1 billion research and development lab at the Chestnut Run Innovation & Science Park (CRISP) will not only be the main production plant for Keytruda in the United States, but also the focal point for …